Attachment 3b
Medical Monitoring Project (MMP) Formative Research
Medical Record Abstraction Form
2013 Surveillance Period Summary Form (SPSF)
VERSION 7.1.0
 
O 
 PTIONAL-
FOR LOCAL USE ONLY
PTIONAL-
FOR LOCAL USE ONLY
| 
			 
 M Abstraction MMP Participant ID: Facility ID: (ID of the facility where abstraction is being conducted) 
 Medical record number: 
 
 
 
 
 
 
 
 
 
 
 
 
 Patient name: 
 
 
 Physician name: | 
 
 
	DEPARTMENT OF HEALTH AND
	HUMAN SERVICES Centers
	for Disease Control & Prevention 
	 
 
Medical Monitoring Project (MMP)
Medical Record Abstraction Form
2013 Surveillance Period Summary Form (SPSF) v7.1.0
| I. ABSTRACTION AND IDENTIFICATION | ||||||
| 
				 
 MMP Participant ID: | ||||||
| 
				 Surveillance Period (SP) 
				 SP start date: 
 
 (12 months prior to date of interview OR 1st contact attempt if no interview obtained) | 
				 
 SP end date: 
 
 (date of interview OR 1st contact attempt if no interview obtained) 
 | |||||
| 
				 
 Date of abstraction: Abstractor ID: 	 
					          Mo.
					                              Day                               
					      Year | ||||||
| 
				 
 Abstraction Facility ID: 
 
 (ID of the facility where abstraction is being conducted) 
 
 | 
				 | |||||
| 
				 Was the documented care abstracted with this form given at another facility (i.e., outside the Abstraction Facility)? 
 | ||||||
| 
				 | 
				 | Yes        Complete
				information about the “Care” Facility  
				 
 | 
 Enter Care Facility ID or indicate that Care Facility was not documented or was outside jurisdiction:   Facility ID 
 
 (ID of the facility where the documented care was provided) | |||
| 
				 | 
				 | 
				 | ||||
| 
				 | 
				 | No Continue to Section II below | 
  
				 | |||
| II. PATIENT DEMOGRAPHICS | ||||||
| 
				M 
 
 
 			 | ||||||
| 
				 Patient’s country of residence during the surveillance period (select ALL that apply): 1 2 3 4 
 
 
 
 5 
 | ||||||
| III. SURVEILLANCE PERIOD SUMMARY FORM SECTIONS – OPTIONAL | ||||||
| Is there documentation of any of the following during the SP? 
 
 | ||||||
| 
				 
      
				 | 
				 
      
				 | |||||
| 
				      
				 | 
				 
      
				 | |||||
| 
				 
      
				 | 
				 
      
				 | |||||
| 
				 
 pneumococcal immunizations were given      
				 | 
				 
      
				 | |||||
| 
				 
      
				 | 
				 | |||||
| IV. COVERAGE FOR MEDICAL CARE 
 
				 | ||||
| 
				 Is there documentation of the type of coverage for medical care or other services during the SP? 
 
 | ||||
| 
				 
				 1
				
				 
				 2
				
				 
				 3
				
				 
				 4
				
				 
				 5
				
				 | 
				 
				 6
				
				 
				 7
				
				 
				 8
				
				 
				 9
				
				 10
				
				 | |||
| 
					 
 
 
				 
 
 12
								 
 
				 13
				
				 
 
 
 
 
 
 
				 
 
 
 
 
 
 
 
 14
				
				 | ||||
| V. OTHER SERVICES | ||||
| 
				 Is there documentation that other services were provided at this facility during the SP? 
 
 | ||||
| 
				 1
				
				 | 
				 09
				
				 | |||
| 
				 2
				
				 | 
				 10
				
				 | |||
| 
				 3
				
				 | 
				 11
				
				 | |||
| 
				 4
				
				 | 
				 12
				
				 | |||
| 
				 5
				
				 | 
				 13
				
				 | |||
| 
				 6
				
				 | 
				 14
				
				 | |||
| 
				 7
				
				 | 
				 15
				
				 | |||
| 
				 8
				
				 | 
				 | |||
| 
				 
				 16
				
				 Specify: | ||||
| 
				 
				 17
				
				 Specify: | ||||
| 
				 
				 18
				
				 Specify: | ||||
| 
				 
				 19
				
				 Specify: | ||||
| 
				 
				 20 Specify: | ||||
| 
				 
				 21 Specify: | ||||
| VI. TUBERCULOSIS (TB), CERVICAL AND ANAL CANCER SCREENING | ||||
| 
				 
 Is there documentation of screening for tuberculosis (TB), or cervical or anal cancer, during the SP? 
								 
								 | ||||
| 
				 Was screening for tuberculosis (TB) performed during the SP? (select one) 
				  1
				
				 
				  2
				
				 
				  3
				
				 
 Date of the most recent tuberculin skin test (TST/PPD/Mantoux) or QuantiFERON test (QFT) during the SP: 
				 
 
 
 
 
 
 
 
 
 					 
 | ||||
| VI. TUBERCULOSIS (TB), CERVICAL AND ANAL CANCER SCREENING cont’d | ||||||||||||||||
| 
				 
 Result of the most recent TST/PPD/Mantoux or QFT test during the SP: (enter one for TST/PPD/Mantoux OR one for QFT) 
 | ||||||||||||||||
| 
				 TST/PPD/Mantoux: (enter OR select one) 
 
 
 Result in millimeters: 
 
 
                    
				 1                    
				 2                    
				 3                    
				 4                      5 | 
				 OR 
 
 
 
 
 
 | 
				 
 QFT: (select one) 
 1 2 3 4 | ||||||||||||||
| 
				 Was screening for cervical or anal cancer performed during the SP? (select one: Yes, No, or Not documented) | ||||||||||||||||
| 
				  1
				
				 | ||||||||||||||||
| 
  2
				
				 was not done | 
 | 
				 Site | Most Recent Result (select one for each documented site) | |||||||||||||
| 
				 | 
				 1 | 
				 1 | 
				 2 | 
				 3 | 
				 4 | |||||||||||
| 
				   3
				
				 screening not documented | ||||||||||||||||
| 
 | 
				 2 | 
				 1 | 
				 2 | 
				 3 | 
				 4 | |||||||||||
| 
				 | 
				 3 | 
				 1 | 
				 2 | 
				 3 | 
				 4 | |||||||||||
| VII. HEPATITIS, INFLUENZA AND PNEUMOCOCCAL IMMUNIZATIONS | ||||||||||||||||
| 
				 Is there documentation of whether or not hepatitis A, B, A and B, influenza or pneumococcal immunizations were given during the SP? 
  
				  
				 | ||||||||||||||||
| 
				 
 
 Was hepatitis A vaccine (Havrix, Vaqta) given during the SP? (select one: Yes, No, or Not documented) | ||||||||||||||||
| 
				 
 
    1
				
				 | 
				 
				 
				   | Date not documented | ||||||||||||||
| 
				    2
				
				 | 
				 
 _____ 
 | 
				 
 
 
 
 
 
 | ||||||||||||||
| 
				   | ||||||||||||||||
| Reason vaccine not given: (select one) | 
				 
 _____ 
 | 
				 
 
 
 
 | ||||||||||||||
| 
				 
 
 | Prior vaccination | 
				 
 
 | Patient declined | |||||||||||||
| 
				 
 | Previously infected | 
				 
 | Not documented | |||||||||||||
| 
				 
 | Other, specify | 
				 | 
				 | |||||||||||||
| 
				 
 | 
				   | 
				 | 
				 | |||||||||||||
| 
				 
 
 
    4
				
				 | 
				 | |||||||||||||||
| 
				 
 
 Was hepatitis B vaccine (Energix B, Recombivax) given during the SP? (select one: Yes, No, or Not documented) | ||||||||||||||||
| 
				 
 
 1 | 
				 
				 
				   | Date not documented | ||||||||||||||
| 
				    2
				
				 | _____ | 
				 
 
 
 
 
 
 
 
 | ||||||||||||||
| 
				   | ||||||||||||||||
| Reason vaccine not given: (select one) | 
				 
 
 _____ | 
				 
 
 
 
 
 | ||||||||||||||
| 
				 
 | 
				 Prior vaccination | 
				 
 | 
 Patient declined | |||||||||||||
| 
				 
 | Previously infected | 
				 
 | Not documented | |||||||||||||
| 
				 
 | 
				 Other, specify | 
				 | 
				 | 
				 
 _____ 
 | 
				 
 
 
 
 
 | |||||||||||
| 
				 
 | 
				 
 | |||||||||||||||
| 
				 
 _____ 
 | 
				 
 
 
 
 | |||||||||||||||
| 
				    4
				
				 | ||||||||||||||||
| VII. HEPATITIS, INFLUENZA AND PNEUMOCOCCAL IMMUNIZATIONS cont’d | |||||||||
| 
				 Was combination hepatitis A and B vaccine (Twinrix) given during the SP? (select one: Yes, No, or Not documented) | |||||||||
| 
				 
 1 | 
				 
				   | Date not documented | |||||||
| 
				    2
				
				 | _____ | 
				 
 
 
 
 
 
 
 
 | |||||||
| 
				   | |||||||||
| Reason vaccine not given: (select one) | 
				 
 
 _____ | 
				 
 
 
 
 
 | |||||||
| 
				 
 | 
				 Prior vaccination | 
				 
 | 
 Patient declined | ||||||
| 
				 
 | Previously infected | 
				 
 | Not documented | ||||||
| 
				 
 | 
				 Other, specify | 
				 | 
				 | 
				 
 _____ 
 | 
				 
 
 
 
 
 | ||||
| 
				 
 | 
				 
 | ||||||||
| 
				 
 _____ 
 | 
				 
 
 
 
 | ||||||||
| 
				    4
				
				 | |||||||||
| 
				 Was influenza vaccine (flushield, fluzone) given during the SP? (select one: Yes, No, or Not documented) | |||||||||
| 
				 
 
 1 | 
				 
				 
 | 
                                     Date | Date not documented | ||||||
| 
				   | 
				 
 
 | 
				 
 
 
 | |||||||
| Reason why vaccine not given: (select one) | 
				 | ||||||||
| 
				 
 | 
				 Allergy to vaccine components | 
				 
 | 
				 Patient declined | ||||||
| 
				 
 | Other, specify | 
				 
 | Not documented | ||||||
| 
				 | 
				 
 | 
				 | 
				 | ||||||
| 
				 | 
				 | ||||||||
| 
				 
    3
				
				 | 
				 | ||||||||
| 
				 Was pneumococcal vaccine (Pneumovax 23, Pneu-Immune 23) given during the SP? (select one: Yes, No, or Not documented) | |||||||||
| 
				 
 
 1 | 
				 
				 
 | 
				 | 
				 | ||||||
| 
				   | Date 
 | Date not documented | |||||||
| Reason why vaccine not given: (select one) | 
				 
 
 
 | 
				 
 
 
 | |||||||
| 
				 
 
 | Prior vaccination | 
				 
 
 | Patient declined | ||||||
| 
				 
 | Other, specify | 
				 
 | Not documented | ||||||
| 
				 | 
				 
 | 
				 | 
				 | ||||||
| 
				    3
				
				 
 | 
				 | ||||||||
| VIII. REFERRALS | |||||||||
| 
				 Is there documentation of any of the following referrals during the SP? 
 
 | |||||||||
| 
				 1 | 
				 
 
 8 | ||||||||
| 
				 2 | 
				  9 | ||||||||
| 
				 3 | 
				 10 | ||||||||
| 
				 4 | 
				 11 | ||||||||
| 
				 5 | 
				 12 | ||||||||
| 
				 6 | 
				 13 | ||||||||
| 
				 7 | 
				 14 | ||||||||
| IX. PREGNANCIES AND OUTCOMES (FEMALES ONLY) | ||
| 
				 
 
 Is there documentation that the patient was pregnant during the SP? 
 
 | ||
| 
				 Number
				of pregnancies that occurred during the SP: 	   
				 
 | ||
| Outcome of the first pregnancy during the SP: (select one and enter date) 
 | 
				 | |
| 
				 1 | 
				 | |
| 
				 2 | Delivery method for the first pregnancy during the SP: 
 | |
| 
				 3 | 
				 1 | |
| 
				 4 | 
				 2 | |
| 
				 5 | 
				 
				3 | |
| 
				 6 | 
				 
				4 | |
| 
				 
 Date of first outcome: 					
				                                                                 
				                                 
				 documented | 
				 5 | |
| 
				 | ||
| 
				 
 Outcome of the second pregnancy during the SP: (select one and enter date) 
 | 
				 | |
| 
				 1 | 
				 | |
| 
				 2 | Delivery method for the second pregnancy during the SP: 
 | |
| 
				 3 | 
				 1 | |
| 
				 4 | 
				 2 | |
| 
				 5 | 
				 
				3 | |
| 
				 6 | 
				 
				4 | |
| 
				 
 Date of second outcome: 						
				                            
				   
				 documented | 
				 5 | |
| 
				 | ||
| 
				 
 Outcome of the third pregnancy during the SP: (select one and enter date) 
 | 
				 | |
| 
				 1 | 
				 | |
| 
				 2 | Delivery method for the third pregnancy during the SP: 
 | |
| 
				 3 | 
				 1 | |
| 
				 4 | 
				 2 | |
| 
				 5 | 
				 
				3 | |
| 
				 6 | 
				 
				4 | |
| 
				 
 Date of third outcome: 						
				                                        
				 documented | 
				 5 | |
| 
				 | ||
| X. SUBSTANCE ABUSE | ||
| 
				 Is there documentation of reported or suspected alcohol abuse or other non-prescribed use of substances, including counseling or treatment for alcohol and/or substance use/abuse, during the SP? 
 
 | ||
| 
				 Alcohol abuse | ||
| 
				      Is
				there documentation of alcohol abuse during the SP?             
				 | ||
| 
				 Other non-prescribed use of substances | ||
| 
				      Is
				there evidence of any injection
				substance use (e.g., track marks) documented during the SP?     
				 
 | ||
| X. SUBSTANCE ABUSE cont’d | ||||
| 
			 Non-prescribed use of substances documented during the SP: (select all that are documented and type of use) | ||||
| 
			 
 
 
 Substance | Type of Use (select all that apply OR select Not documented) | |||
| Injection | Non-Injection | Not documented | ||
| 
			   1 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			   2 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			   3 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			   4 | 
			 | 
			 | 
			 | |
| 
			   5 | 
			 | 
			 | 
			 | |
| 
			   6 | 
			 | 
			 | 
			 | |
| 
			   7 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			   8 | 
			 | 
			 | 
			 | |
| 
			   9 | 
			 | 
			 | 
			 | |
| 
			 10 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			 
 11 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			 12 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			 13 | 
			 | 
			 | 
			 | |
| 
			 14 | 
			 | 
			 | 
			 | |
| 
			 15 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| 
			 16 | 
			 | 
			 | 
			 | |
| 
			 17 | 
			 | 
			 | 
			 | |
| 
			 18 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | |
| 
			 1 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | |
| 
			 2 Specify: | 
			 
 
 
 
 | 
			 
 
 
 
 | 
			 
 
 
 
 | |
| 
			 21 | 
			 
 
 | 
			 
 
 | 
			 
 
 | |
| XI. MORTALITY DATA | ||||
| 
			 Is there documentation that the patient died during the SP? 
 
 | ||||
| 
			 
 
 
 
 
 
 Date
			of death during the SP:						 
 
 Cause
			of death: (select
			one)
			    
			                                               
						 | ||||
| 
			 
 Diagnoses
			at death:  (enter
			all documented diagnoses)
			          
			 | ||||
| 
			 
 1. | 6. | |||
| 
			 
 2. | 7. | |||
| 
			 
 3. | 8. | |||
| 
			 
 4. | 9. | |||
| 
			 
 5. | 10. | |||
 
FOR LOCAL USE ONLY
M MP
SPSF v7.1.0
MP
SPSF v7.1.0
    
                                                                     
                                                                     
                      Abstraction 
MMP Participant ID: Facility ID:
(ID of the facility where abstraction is being conducted)
| XII. OTHER FACILITIES cont’d | |
| Facility/Provider Name | Contact Information | 
| 
			 
 
 1. ____________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 2. ____________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 3. ____________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 4. ____________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 5. ___________________________________________ 
 
 
 ______________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
 
FOR LOCAL USE ONLY
M MP
SPSF v7.1.0
MP
SPSF v7.1.0
    
                                                                     
                                                                     
                      Abstraction 
MMP Participant ID: Facility ID:
(ID of the facility where abstraction is being conducted)
| XII. OTHER FACILITIES cont’d | |
| Facility/Provider Name | Contact Information | 
| 
			 
 
 6. ____________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 7. ____________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 8. ____________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 9. ____________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
| 
			 
 
 10. ___________________________________________ 
 
 
 ______________________________________________ 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ 
 
 
 
 ______________________________________________ | 
			 
 Street: ____________________________________________________________________ 
 
 
 
 _____________________________________________________________________ 
 
 City: ____________________________________________________________________ 
 
 
 
 State: _____ _____ ZIP code: 
 
 
 Telephone: | 
OPTIONAL
 -
FOR LOCAL USE ONLY
-
FOR LOCAL USE ONLY
M MP
SPSF v7.1.0
MP
SPSF v7.1.0
    
                                                                     
                                                                     
                      Abstraction 
MMP Participant ID: Facility ID:
(ID of the facility where abstraction is being conducted)
| XIII. REMARKS | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 
 | 
| 
			 | 
| 
			 
 | 
	 
		Page
		
	
	
| File Type | application/msword | 
| File Title | Medical monitoring project (MMP) | 
| Author | Rita Morgan | 
| Last Modified By | Bertolli, Jeanne (CDC/OID/NCHHSTP) | 
| File Modified | 2013-06-20 | 
| File Created | 2013-06-20 |